Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea

被引:0
|
作者
Sclar, David Alexander [1 ]
Robison, Linda M. [1 ]
Oganov, Ambartsum M. [1 ]
Schmidt, Jennifer M. [1 ]
Bowan, Kurt A. [1 ]
Castillo, Leigh V. [1 ]
机构
[1] Midwestern Univ, Coll Pharm, Glendale, AZ USA
关键词
Public Health; Internal Medicine; Vancomycin; Healthcare System; Metronidazole;
D O I
10.1007/s40261-013-0059-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:229 / 229
页数:1
相关论文
共 50 条
  • [21] Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea
    Harbarth, S
    Samore, MH
    Carmeli, Y
    JOURNAL OF HOSPITAL INFECTION, 2001, 48 (02) : 93 - 97
  • [22] Study on Clostridium difficile-associated diarrhoea in a hospital in Japan
    Ito, Y.
    Matsushita, T.
    Takahashi, Y.
    Nakamura, T.
    Hayashi, K.
    Morita, E.
    Kato, H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S552 - S552
  • [23] The Management of Clostridium difficile-associated Diarrhoea in a Community Hospital
    Tomkins, K.
    Raynor, J.
    Rothwell, L.
    DeSilva, J.
    Wilson, C.
    WEST INDIAN MEDICAL JOURNAL, 2011, 60 (01): : 57 - 60
  • [24] Risk Factors for Recurrence of Clostridium Difficile-Associated Diarrhoea
    Samie, Ahmed Abdel
    Traub, Marc
    Bachmann, Klaus
    Kopischke, Karolin
    Theilmann, Lorenz
    HEPATO-GASTROENTEROLOGY, 2013, 60 (126) : 1351 - 1354
  • [26] Fidaxomicin for Clostridium difficile-Associated DiarrhoeaEpidemiological Method for Estimation of Warranted Price
    David Alexander Sclar
    Linda M. Robison
    Ambartsum M. Oganov
    Jennifer M. Schmidt
    Kurt A. Bowen
    Leigh V. Castillo
    Clinical Drug Investigation, 2012, 32 (8) : e17 - e24
  • [27] Clostridium difficile-associated diarrhoea (CDAD): new and contentious issues
    Gouliouris, Theodoros
    Forsyth, Duncan R.
    Brown, Nicholas M.
    AGE AND AGEING, 2009, 38 (05) : 497 - 500
  • [28] Global research on Clostridium difficile-associated diarrhoea: A visualized study
    Zyoud, Sa'ed H.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (28) : 3720 - 3731
  • [29] A COMPARISON OF THE COST-EFFECTIVENESS OF FIDAXOMICIN, METRONIDAZOLE, AND VANCOMYCIN, IN THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE
    Madkour, N.
    Bounthavong, M.
    Hsu, D., I
    VALUE IN HEALTH, 2012, 15 (04) : A138 - A139
  • [30] The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea
    Parkes, Gareth C.
    Sanderson, Jeremy D.
    Whelan, Kevin
    LANCET INFECTIOUS DISEASES, 2009, 9 (04): : 237 - 244